Lysophosphatidylcholine as a predictor of postoperative complications after colorectal cancer surgery

[1]  D. McMillan,et al.  A Postoperative Systemic Inflammation Score Predicts Short- and Long-Term Outcomes in Patients Undergoing Surgery for Colorectal Cancer , 2017, Annals of Surgical Oncology.

[2]  D. McMillan,et al.  Examination of a CRP first approach for the detection of postoperative complications in patients undergoing surgery for colorectal cancer , 2017, Medicine.

[3]  I. Dijkstra,et al.  Postoperative Interleukin-6 Level and Early Detection of Complications After Elective Major Abdominal Surgery , 2016, Annals of surgery.

[4]  D. McMillan,et al.  Postoperative C-reactive protein measurement predicts the severity of complications following surgery for colorectal cancer , 2015, International Journal of Colorectal Disease.

[5]  Peter J. Richardson,et al.  Infectious postoperative complications decrease long-term survival in patients undergoing curative surgery for colorectal cancer: a study of 12,075 patients. , 2015, Annals of surgery.

[6]  Sang-Bum Hong,et al.  Impact of serial measurements of lysophosphatidylcholine on 28-day mortality prediction in patients admitted to the intensive care unit with severe sepsis or septic shock. , 2014, Journal of critical care.

[7]  D. McMillan,et al.  The impact of surgical specialisation on survival following elective colon cancer surgery , 2014, International Journal of Colorectal Disease.

[8]  Juhee Cho,et al.  Impact of Eastern Cooperative Oncology Group Performance Status on hospital mortality in critically ill patients. , 2014, Journal of critical care.

[9]  D. Jayne,et al.  The Impact of Postoperative Complications on Long-term Quality of Life After Curative Colorectal Cancer Surgery , 2014, Annals of surgery.

[10]  U. Lopes,et al.  Lysophosphatidylcholine Triggers TLR2- and TLR4-Mediated Signaling Pathways but Counteracts LPS-Induced NO Synthesis in Peritoneal Macrophages by Inhibiting NF-κB Translocation and MAPK/ERK Phosphorylation , 2013, PloS one.

[11]  J. Huh,et al.  Clinical significance of enzymatic lysophosphatidylcholine (LPC) assay data in patients with sepsis , 2012, European Journal of Clinical Microbiology & Infectious Diseases.

[12]  D. McMillan,et al.  C-reactive Protein as a Predictor of Postoperative Infective Complications after Curative Resection in Patients with Colorectal Cancer , 2012, Annals of Surgical Oncology.

[13]  Justin B Dimick,et al.  Hospital Volume and Failure to Rescue With High-risk Surgery , 2011, Medical care.

[14]  D. McMillan,et al.  The Impact of Perioperative Risk, Tumor Pathology and Surgical Complications on Disease Recurrence Following Potentially Curative Resection of Colorectal Cancer , 2011, Annals of surgery.

[15]  R. Warschkow,et al.  Diagnostic accuracy of C-reactive protein and white blood cell counts in the early detection of inflammatory complications after open resection of colorectal cancer: a retrospective study of 1,187 patients , 2011, International Journal of Colorectal Disease.

[16]  A. Mirnezami,et al.  Increased Local Recurrence and Reduced Survival From Colorectal Cancer Following Anastomotic Leak: Systematic Review and Meta-Analysis , 2011, Annals of surgery.

[17]  M. Cuesta,et al.  The surgical stress response and postoperative immune function after laparoscopic or conventional total mesorectal excision in rectal cancer: a randomized trial , 2010, International Journal of Colorectal Disease.

[18]  A. Nesbakken,et al.  Short term outcome after emergency and elective surgery for colon cancer , 2009, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[19]  J. Kabarowski.  G2A and LPC: regulatory functions in immunity. , 2009, Prostaglandins & other lipid mediators.

[20]  H. Nielsen,et al.  Diagnostic Accuracy of C-reactive Protein for Intraabdominal Infections After Colorectal Resections , 2009, Journal of Gastrointestinal Surgery.

[21]  F. Russo,et al.  Lipoprotein(a), lipids and proinflammatory cytokines in patients undergoing major abdominal surgery , 2006, The British journal of surgery.

[22]  J. Blache,et al.  Procalcitonin, interleukin 6 and systemic inflammatory response syndrome (SIRS): early markers of postoperative sepsis after major surgery. , 2005, British journal of anaesthesia.

[23]  K. Tracey,et al.  Suppression of HMGB1 release by stearoyl lysophosphatidylcholine:an additional mechanism for its therapeutic effects in experimental sepsis. , 2005, Journal of lipid research.

[24]  K. Slim,et al.  Postoperative mortality and morbidity in French patients undergoing colorectal surgery: results of a prospective multicenter study. , 2005, Archives of surgery.

[25]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.

[26]  M. Menger,et al.  Surgical trauma: hyperinflammation versus immunosuppression? , 2004, Langenbeck's Archives of Surgery.

[27]  K. Tracey,et al.  Lipid unites disparate syndromes of sepsis , 2004, Nature Medicine.

[28]  H. Suh,et al.  Therapeutic effects of lysophosphatidylcholine in experimental sepsis , 2004, Nature Medicine.

[29]  G. Schmitz,et al.  Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients Published, JLR Papers in Press, January 16, 2003. DOI 10.1194/jlr.M200401-JLR200 , 2003, Journal of Lipid Research.

[30]  M. Blajchman.  Immunomodulation and Blood Transfusion , 2002, American journal of therapeutics.

[31]  O. Witte,et al.  Lysophosphatidylcholine as a ligand for immunoregulation. , 2002, Biochemical pharmacology.

[32]  Y. Soda,et al.  An enzymatic assay for lysophosphatidylcholine concentration in human serum and plasma. , 2002, Clinical biochemistry.

[33]  O. Witte,et al.  Lysophosphatidylcholine as a Ligand for the Immunoregulatory Receptor G2A , 2001, Science.

[34]  A. Satterthwaite,et al.  Mice lacking the orphan G protein-coupled receptor G2A develop a late-onset autoimmune syndrome. , 2001, Immunity.

[35]  E. Bulger,et al.  Lipid mediators in the pathophysiology of critical illness , 2000, Critical care medicine.

[36]  K. Kugiyama,et al.  Biphasic regulation of transcription factor nuclear factor-kappaB activity in human endothelial cells by lysophosphatidylcholine through protein kinase C-mediated pathway. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[37]  H. Gilliland,et al.  The Choice of Anesthetic Maintenance Technique Influences the Antiinflammatory Cytokine Response to Abdominal Surgery , 1997, Anesthesia and analgesia.

[38]  M. Gimbrone,et al.  Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells. , 1994, The Journal of clinical investigation.

[39]  R. Sauerwein,et al.  Cytokine Patterns in Patients After Major Vascular Surgery, Hemorrhagic Shock, and Severe Blunt Trauma Relation with Subsequent Adult Respiratory Distress Syndrome and Multiple Organ Failure , 1993, Annals of surgery.

[40]  V. Aidinis,et al.  Lysoglycerophospholipids in chronic inflammatory disorders: the PLA(2)/LPC and ATX/LPA axes. , 2013, Biochimica et biophysica acta.